Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

1987 • 2,734 citations

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1999 • 1,106 citations

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

1989 • 1,035 citations

AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE

1977 • 815 citations

Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1997 • 780 citations

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1987 • 678 citations

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

2016 • 476 citations

Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables

1997 • 432 citations

Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial

1993 • 358 citations

Randomized Clinical Trial of Plantago Ovata Seeds (Dietary Fiber) As Compared With Mesalamine in Maintaining Remission in Ulcerative Colitis

1999 • 316 citations

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI

2000 • 307 citations

A Comparison of Budesonide and Mesalamine for Active Crohn's Disease

1998 • 305 citations

A Meta-Analysis and Overview of The Literature on Treatment Options for Left-Sided Ulcerative Colitis and Ulcerative Proctitis

2000 • 271 citations

Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.

1993 • 271 citations

Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease

1995 • 270 citations

TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS

1981 • 253 citations

Sulfasalazine

1983 • 241 citations

Sulfasalazine Revisited

1993 • 233 citations

A Controlled Trial Comparing Ciprofloxacin With Mesalazine for The Treatment of Active Crohn's Disease

1999 • 233 citations

Sulfasalazine

1984 • 233 citations

Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's disease

1994 • 215 citations

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis

1999 • 215 citations

Oral Mesalamine (Asacol) for Mildly to Moderately Active Ulcerative Colitis

1991 • 211 citations

Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease

1995 • 210 citations

Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis

1995 • 197 citations

Azodisal sodium in the treatment of ulcerative colitis

1986 • 197 citations

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis

1998 • 196 citations

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease

1999 • 195 citations

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

1988 • 193 citations

Beclomethasone dipropionate (3mg) versus 5-aminosalicylic acid (2g) versus the combination of both (3mg/2g) as retention enemas in active ulcerative proctitis

1996 • 190 citations

A Comparison of Budesonide and Mesalamine for Active Crohn's Disease

2001 • 183 citations

Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis

1988 • 176 citations

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

1997 • 166 citations

An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis

1996 • 154 citations

Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives

1996 • 151 citations

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study

1993 • 151 citations

A Randomized, Double-Blind, Placebo-Controlled Trial of the Oral Mesalamine (5-ASA) Preparation, Asacol, in the Treatment of Symptomatic Crohn??s Colitis and Ileocolitis

1994 • 149 citations

5-Aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis

1988 • 144 citations

Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis

1995 • 134 citations

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease

1992 • 132 citations

5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®

1987 • 132 citations

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.

1982 • 127 citations

Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.

1994 • 124 citations

Double-Blind Comparison of Slow-Release 5-Aminosalicylateand Sulfasalazine in Remission Maintenance in Ulcerative Colitis

1988 • 124 citations

Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine

1987 • 123 citations

Comparison of budesonide and 5‐aminosalicylic acid enemas in active distal ulcerative colitis

1995 • 122 citations

Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositories

1987 • 119 citations

Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth.

1983 • 118 citations

A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis

1997 • 116 citations

Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.

1991 • 114 citations

Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial

1999 • 113 citations

Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis

1995 • 109 citations

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs disease

1996 • 107 citations

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

2002 • 107 citations

Mesalazine (5-Aminosalicylic Acid) Suppositories in the Treatment of Ulcerative Proctitis or Distal Proctosigmoiditis: A Randomized Controlled Trial

1990 • 102 citations

Long-Term Use of Mesalamine (Rowasa) Suppositories in Remission Maintenance of Ulcerative Proctitis

2000 • 98 citations

Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis

1992 • 95 citations

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months

1998 • 95 citations

Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis

1992 • 94 citations

Mesalazine Suppositories versus Hydrocortisone Foam in Patients with Distal Ulcerative Colitis:A Comparison of the Efficacy and Practicality of Two Topical Treatment Regimens

1995 • 93 citations

Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.

1994 • 93 citations

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.

1988 • 90 citations

Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazine

1988 • 89 citations

Comparative efficacy of coated, oral 5‐aminosalicylic acid (Claversal*) and sulphasalazine for maintaining remission of ulcerative colitis

1989 • 85 citations

Is maintenance therapy always necessary for patients with ulcerative colitis in remission?

1999 • 83 citations

Mesalamine and relapse prevention in Crohn's disease

2000 • 80 citations

Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of a multicentered placebo-controlled trial

1998 • 79 citations

5-Aminosalicylic Acid as Enemas or Suppositories in Distal Ulcerative Colitis?

1988 • 78 citations

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.

1989 • 77 citations

Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease

1992 • 76 citations

Optimum dose of olsalazine for maintaining remission in ulcerative colitis.

1994 • 75 citations

Oral Delayed-Release Mesalazine

1999 • 74 citations

5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.

1990 • 72 citations

A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.

1996 • 72 citations

Olsalazine in maintenance of clinical remission in patients with ulcerative colitis

1993 • 71 citations

Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis

1993 • 71 citations

5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.

1986 • 69 citations

Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial.

1993 • 68 citations

Prolonged-Release Mesalazine*

2000 • 65 citations

Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months

1992 • 60 citations

What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?

1998 • 60 citations

Double-Blind Comparison of Olsalazine and Sulphasalazine in Active Ulcerative Colitis

1988 • 59 citations

A new mesalazine gel enema in the treatment of left‐sided ulcerative colitis: a randomized controlled multicentre trial

1999 • 59 citations

Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.

1989 • 58 citations

Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis

1998 • 58 citations

A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.

1996 • 58 citations

Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day

1992 • 56 citations

Coated Oral 5-Aminosalicylic Acid (Claversal) Is Equivalent to Sulfasalazine for Remission Maintenance in Ulcerative Colitis

1995 • 55 citations

Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.

1992 • 55 citations

A Controlled Double Blind Multicenter Study of the Effectiveness of 5-Aminosalicylic Acid in Patients with Crohnʼs Disease in Remission

1995 • 54 citations

Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease

1995 • 54 citations

Double-blind placebo-controlled study of olsalazine in the treatment of ulcerative colitis.

1990 • 53 citations

Controlled trial of oral 5‐aminosalicylic acid for the prevention of early relapse in Crohn's disease

1997 • 50 citations

A defence of the small clinical trial: evaluation of three gastroenterological studies.

1986 • 49 citations

Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation

1990 • 48 citations

Comparison of 5-Aminosalicylic Acid (3 g) and Prednisolone Phosphate Sodium Enemas (30 mg) in the Treatment of Distal Ulcerative Colitis: A Prospective, Randomized, Double-Blind Trial

1988 • 46 citations

Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.

1993 • 44 citations

Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.

1992 • 44 citations

Medical therapy to reduce postoperative Crohn's disease recurrence

2000 • 44 citations

Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.

1995 • 43 citations

A Double-Blind, Placebo Controlled, Multicentre Study of the Efficacy And Safety of 5-Aminosalicylic Acid Tablets in the Treatment of Ulcerative Colitis

1990 • 42 citations

Medical Therapy To Reduce Postoperative Crohn's Disease Recurrence

2000 • 42 citations

Olsalazine in the Treatment of Active Ulcerative Colitis: A Placebo Controlled Clinical Trial and Assessment of Drug Disposition

1988 • 36 citations

Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.

1995 • 35 citations

Prospective, Randomized, Double-Blind Comparison of Benzalazine and Sulfasalazine in the Treatment of Active Ulcerative Colitis

1988 • 35 citations

Mesalamine capsules enhance the quality of life for patients with ulcerative colitis

1994 • 35 citations

Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease

1995 • 31 citations

5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.

1994 • 31 citations

Case report of a patient with multiple lesions of the stomach, including multiple cancers and an adenomatous polyp

1995 • 30 citations

Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.

2000 • 30 citations

[Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial].

1992 • 27 citations

Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study.

1995 • 25 citations

Budesonid-Schaum als neues Therapieprinzip bei der distalen Colitis ulcerosa im Vergleich mit Mesalazin-Klysmen. Eine offene, kontrollierte, randomisierte und prospektive multizentrische Pilotstudie

2000 • 23 citations

Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized, double-blind multicenter trial. Danish 5-ASA Group.

1987 • 19 citations

5-Aminosalicylic Acid Enemas to Maintain Remission in Left-Sided Ulcerative Colitis

1995 • 15 citations

Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.

1990 • 7 citations